Pharmaceutical Executive
A look at how Medical Affairs is transitioning to a new and fundamental strategic role within pharma and ways MA can step up to own this role within a pharma company, particularly within emerging markets.
Ryan Bate
Advertisement
Articles by Ryan Bate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
2
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
3
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5